Search Results for: Candesartan

October 23, 2024October 23, 2024

Combination of the chemokine receptor type 2 (CCR2) antagonist DMX-200 and candesartan for COVID-19: a randomised controlled trial.

Publication date: Oct 22, 2024 To determine whether a chemokine receptor type 2 antagonist, DMX-200 (repagermanium), in combination with an angiotensin receptor blocker, candesartan, improves clinical outcomes in people with ... Read more

November 17, 2024November 17, 2024

Cannabinoid regulation of angiotensin II-induced calcium signaling in striatal neurons.

Parkinson's Disease Literature

Publication date: Nov 15, 2024 Calcium ion (Ca) homeostasis is crucial for neuron function and neurotransmission. This study focused on the actions mediated by the CB receptor (CBR), the most ... Read more

October 20, 2024October 20, 2024

Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination.

Coronavirus Literature

Publication date: Oct 18, 2024 While Coronavirus disease 2019 (COVID-19) vaccines have proven to be both effective and generally safe, rare but severe adverse events following immunization (AEFIs) are described. ... Read more

October 4, 2024October 4, 2024

A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination.

Coronavirus Literature

Publication date: Sep 13, 2024 In this pilot study, a multi-parametric analysis comparing immune responses in sera of adult healthy subjects (HS) or people with type 2 diabetes mellitus (T2D) ... Read more

October 4, 2024October 4, 2024

A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination.

Coronavirus Literature

October 4, 2024October 4, 2024

A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination.

Coronavirus Literature

October 4, 2024October 4, 2024

A Serum Multi-Parametric Analysis Identifies an Early Innate Immune Signature Associated to Increased Vaccine-Specific Antibody Production and Seroconversion in Simultaneous COVID-19 mRNA and Cell-Based Quadrivalent Influenza Vaccination.

Coronavirus Literature